Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
23.36
+0.29 (1.28%)
At close: Aug 21, 2026, 4:00 PM EDT
23.03
-0.33 (-1.40%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.38 billion as of August 21, 2026. Its market cap has increased by 395.88% in one year.
Market Cap
1.38B
Enterprise Value
918.78M
1-Year Change
395.88%
Ranking
Category
Stock Price
$23.36
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has increased from $1.30B to $1.38B, an increase of 6.39%. That is a compound annual growth rate of 1.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.38B | 172.88% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 1.44B |
| Savara | 1.42B |
| Latigo Biotherapeutics | 1.40B |
| Replimune Group | 1.40B |
| Cullinan Therapeutics | 1.40B |
| Omeros | 1.39B |
| Jade Biosciences | 1.37B |
| MannKind | 1.37B |